Your cart
Your cart is empty
Continue shoppingMore Information (Symbion / 150mg)
Active Ingredients
Nilotinib (as hydrochloride) 150mg
Free-From
Gluten free
Indicators
NILOTAS is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukaemia (CML) in chronic phase, treatment of adults with chronic phase and accelerated phase Philadelphia chromosome positive chronic myeloid leukaemia (CML) resistant to or intolerant of prior therapy including imatinib.
Tablet Description
Light yellow coloured blend filled in size '1' hard gelatin capsules with red opaque colour body and cap imprinted with 'MN4' with black ink.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Symbion / 200mg)
Active Ingredients
Nilotinib (as hydrochloride) 200mg
Free-From
Gluten free
Indicators
NILOTAS is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukaemia (CML) in chronic phase, treatment of adults with chronic phase and accelerated phase Philadelphia chromosome positive chronic myeloid leukaemia (CML) resistant to or intolerant of prior therapy including imatinib.
Tablet Description
Light yellow coloured blend filled in size '0' hard gelatin capsules with,Light yellow opaque colour body and cap imprinted with 'MN3' with black ink.
Storage Conditions
Store below 25 degrees Celsius.
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (CH2 / 150mg)
Active Ingredients
Nilotinib (as hydrochloride) 150mg
Free-From
Gluten free
Indicators
NILOTAS is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukaemia (CML) in chronic phase, treatment of adults with chronic phase and accelerated phase Philadelphia chromosome positive chronic myeloid leukaemia (CML) resistant to or intolerant of prior therapy including imatinib.
Tablet Description
Light yellow coloured blend filled in size '1' hard gelatin capsules with red opaque colour body and cap imprinted with 'MN4' with black ink.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (CH2 / 200mg)
Active Ingredients
Nilotinib (as hydrochloride) 200mg
Free-From
Gluten free
Indicators
NILOTAS is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukaemia (CML) in chronic phase, treatment of adults with chronic phase and accelerated phase Philadelphia chromosome positive chronic myeloid leukaemia (CML) resistant to or intolerant of prior therapy including imatinib.
Tablet Description
Light yellow colored blend filled in size '0' hard gelatin capsules with,Light yellow opaque colour body and cap imprinted with 'MN3' with black ink.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
Connecting Care, Simplifying Supply.
At Pharmacor, we bridge the gap between healthcare providers and seamless supply solutions, ensuring care is always within reach.
